Oncology
Melinda Telli, MD
Professor of Medicine (Oncology); Director, Breast Cancer Program; Associate Director of Clinical Research, Stanford Cancer Institute; Associate Director, Stanford Women's Cancer Center
Dr. Melinda L. Telli is a Professor of Medicine in the Division of Medical Oncology at Stanford University School of Medicine, where she serves as Director of the Breast Cancer Program, Associate Director of Clinical Research at the Stanford Cancer Institute, and Associate Director of the Stanford Women's Cancer Center. Her clinical practice focuses on breast cancer, particularly triple-negative breast cancer, BRCA1/2 mutation-associated breast cancer, hereditary breast cancer, metastatic breast
24+
Years in Practice
Credentials
Board Certifications
- American Board of Internal Medicine, Internal Medicine (2024)
- American Board of Internal Medicine, Medical Oncology (2024)
Education & Training
- B.A., University of Pennsylvania, Biology, with Distinction (1996)
- M.D., George Washington University, Medicine, with Distinction (2002)
- Residency, Stanford University, Internal Medicine (2005)
- Fellowship, Stanford University, Medical Oncology (2008)
Peer Recognition
2017-2023 (7 years)
2019-2025 (7 years)
2017-2022, 2024-2025 (8 years)
2023
Recognition & Leadership
Awards & Honors
- Fellow of the American Society of Clinical Oncology, American Society of Clinical Oncology (2024)
- Increasing Access to Cancer Clinical Trials Star Award, Stanford Medicine (2023)
- Visionary Award, Susan G. Komen San Francisco Bay Area (2019)
- Hero Award, Triple Negative Breast Cancer Foundation (2018)
- Komen Leadership Award, Susan G. Komen for the Cure (2015-2024)
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Stanford Cancer Institute
- Stanford Health Care
Languages
English
Experience
24+ years in practice